T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study

✍ Scribed by P. Andreone; S. Roberts; S. Pol; Z. Younossi; M. Diago; E.J. Lawitz; R. Focaccia; G.R. Foster; A. Horban; I. Lonjon-Domanec; R. DeMasi; R. Van Heeswijk; G. Picchio; J. Witek; S. Zeuzem

• Book ID: 118648281
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 79 KB
• Volume: 44
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/s1590-8658(12)60063-2